Atossa Therapeutics, Inc. (ATOS)
1.595
-0.16
(-8.86%)
USD |
NASDAQ |
Nov 20, 16:00
1.62
+0.02
(+1.57%)
After-Hours: 20:00
Atossa Therapeutics Price to Book Value : 0.7322 for Nov. 20, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2026 | 0.7322 |
| November 19, 2026 | 0.8033 |
| November 18, 2026 | 0.8309 |
| November 17, 2026 | 0.8722 |
| November 16, 2026 | 0.886 |
| November 13, 2026 | 0.8997 |
| November 12, 2026 | 0.8906 |
| November 11, 2026 | 0.9319 |
| November 10, 2026 | 0.9824 |
| November 09, 2026 | 0.9778 |
| November 06, 2026 | 0.9732 |
| November 05, 2026 | 0.9273 |
| November 04, 2026 | 0.9732 |
| November 03, 2026 | 1.070 |
| November 02, 2026 | 1.056 |
| October 30, 2026 | 0.9961 |
| October 29, 2026 | 1.024 |
| October 28, 2026 | 1.088 |
| October 27, 2026 | 1.092 |
| October 26, 2026 | 1.125 |
| October 23, 2026 | 1.194 |
| October 22, 2026 | 1.249 |
| October 21, 2026 | 1.161 |
| October 20, 2026 | 1.166 |
| October 19, 2026 | 1.175 |
| Date | Value |
|---|---|
| October 16, 2026 | 1.336 |
| October 15, 2026 | 1.216 |
| October 14, 2026 | 1.276 |
| October 13, 2026 | 1.175 |
| October 12, 2026 | 1.096 |
| October 09, 2026 | 1.120 |
| October 08, 2026 | 1.111 |
| October 07, 2026 | 1.129 |
| October 06, 2026 | 1.125 |
| October 05, 2026 | 1.125 |
| October 02, 2026 | 1.074 |
| October 01, 2026 | 1.042 |
| September 30, 2026 | 0.8951 |
| September 29, 2026 | 0.7402 |
| September 28, 2026 | 0.729 |
| September 25, 2026 | 0.7067 |
| September 24, 2026 | 0.7625 |
| September 23, 2026 | 0.8108 |
| September 22, 2026 | 0.8406 |
| September 21, 2026 | 0.8369 |
| September 18, 2026 | 0.8257 |
| September 17, 2026 | 0.8927 |
| September 16, 2026 | 0.9001 |
| September 15, 2026 | 0.8815 |
| September 14, 2026 | 0.9224 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.131 |
| Alnylam Pharmaceuticals, Inc. | 5.343 |
| Anika Therapeutics, Inc. | 1.288 |
| Savara, Inc. | 8.118 |
| Arrowhead Pharmaceuticals, Inc. | 116.18 |
Price to Book Value Related Metrics
| PEG Ratio | -0.0103 |
| Price | 1.595 |
| Earnings Yield | -244.5% |
| Market Cap | 15.92M |
| PEGY Ratio | -0.0103 |